Motus GI Holdings Inc (NASDAQ:MOTS) – Stock analysts at Oppenheimer decreased their FY2019 earnings per share (EPS) estimates for shares of Motus GI in a research note issued on Tuesday, June 11th. Oppenheimer analyst S. Lichtman now anticipates that the company will post earnings per share of ($1.08) for the year, down from their prior forecast of ($1.05). Oppenheimer currently has a “Buy” rating and a $10.00 price target on the stock. Oppenheimer also issued estimates for Motus GI’s Q4 2019 earnings at ($0.24) EPS, FY2020 earnings at ($0.77) EPS and FY2021 earnings at ($0.35) EPS.
Motus GI (NASDAQ:MOTS) last released its quarterly earnings results on Friday, May 10th. The company reported ($0.29) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.29).
Other equities research analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Motus GI from a “buy” rating to a “hold” rating in a research report on Tuesday, May 7th. ValuEngine cut shares of Motus GI from a “buy” rating to a “hold” rating in a research report on Thursday, May 23rd. Finally, Piper Jaffray Companies cut their price objective on shares of Motus GI from $8.00 to $6.00 in a research report on Friday, May 10th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $8.60.
MOTS stock opened at $3.45 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 6.31 and a current ratio of 6.36. Motus GI has a 52 week low of $2.34 and a 52 week high of $10.66. The stock has a market capitalization of $75.29 million, a P/E ratio of -2.80 and a beta of 2.03.
Institutional investors and hedge funds have recently bought and sold shares of the stock. Renaissance Technologies LLC bought a new stake in Motus GI during the first quarter worth about $43,000. Spark Investment Management LLC lifted its position in Motus GI by 73.5% during the first quarter. Spark Investment Management LLC now owns 28,900 shares of the company’s stock worth $112,000 after purchasing an additional 12,245 shares during the period. Maven Securities LTD bought a new stake in Motus GI during the fourth quarter worth about $167,000. Eaton Vance Management lifted its position in Motus GI by 75.0% during the fourth quarter. Eaton Vance Management now owns 70,000 shares of the company’s stock worth $218,000 after purchasing an additional 30,000 shares during the period. Finally, Mesirow Financial Investment Management Inc. bought a new stake in Motus GI during the first quarter worth about $350,000. 35.30% of the stock is owned by institutional investors and hedge funds.
Motus GI Company Profile
Motus GI Holdings, Inc operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Featured Article: How Do Investors Open a Backdoor Roth IRA?
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.